NGM Clinical Study Site 482 — Seattle, Washington

NGM Clinical Study Site 482 is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

NGM Clinical Study Site 482 has participated in 1 clinical trials.

Therapeutic areas: Compensated Cirrhosis, Nonalcoholic Steatohepatitis.

Sponsors: NGM Biopharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NGM Clinical Study Site 482?

NGM Clinical Study Site 482 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NGM Clinical Study Site 482 conducted?

NGM Clinical Study Site 482 has 1 clinical trials on record. Their work covers Compensated Cirrhosis, Nonalcoholic Steatohepatitis.

Is NGM Clinical Study Site 482 accredited by Crixeo Health?

NGM Clinical Study Site 482 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NGM Clinical Study Site 482?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.